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The rapid growth of the embryo places severe demands on the ability of the cardiovascular system to deliver oxygen to cells. To meet this need,
erythroid progenitors rapidly expand in the fetal liver microenvironment such that by E14.5, erythropoiesis predominates in the fetal liver. In this
report we show that the BMP4/Smad5 dependent stress erythropoiesis pathway plays a key role in the expansion of erythroid progenitors in the
fetal liver. These data show that the fetal liver contains two populations of erythroid progenitors. One population resembles the steady state
erythroid progenitors found in the adult bone marrow. While the second population exhibits the properties of stress erythroid progenitors found in
adult spleen. Here we demonstrate that defects in BMP4/Smad5 signaling preferentially affect the expansion of the stress erythroid progenitors in
the fetal liver leading to fetal anemia. These data suggest that steady state erythropoiesis is unable to generate sufficient erythrocytes to maintain
the rapid growth of the embryo leading to the induction of the BMP4 dependent stress erythropoiesis pathway. These observations underscore the
similarities between fetal erythropoiesis and stress erythropoiesis.
© 2008 Elsevier Inc. All rights reserved.Keywords: Fetal liver; Erythropoiesis; BMP4Introduction
Hematopoiesis during embryogenesis occurs in distinct
anatomical locations of the mammalian embryo. In the
mouse, the first blood cells arise in yolk sac blood islands at
embryonic day 7.5 (E7.5) (Palis et al., 1999). These ‘primitive’
erythroblasts are large, initially nucleated, and synthesize
embryonic globins (Kingsley et al., 2004). In contrast,
‘definitive’ erythrocytes are smaller, enucleated, and express
adult globins. From E9.5 to E11.5, definitive progenitors
formed in the yolk sac and the Aorta–Gonad–Mesonephros
(AGM) region are thought to seed the fetal liver, which remains
the predominant site of definitive erythropoiesis in the embryo
until birth (McGrath and Palis, 2005).⁎ Corresponding author. 115 Henning Building, The Pennsylvania State
University, University Park, PA 16802, USA. Fax: +1 814 863 6140.
E-mail address: rfp5@psu.edu (R.F. Paulson).
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doi:10.1016/j.ydbio.2008.01.047Unlike the bone marrow, where myelopoiesis predominates,
erythropoiesis is the primary function of the fetal liver from
E12.5 until about E18.5, after which the bone marrow becomes
the primary erythropoietic organ in the adult (Johnson and
Moore, 1975; Palis et al., 1999). Fetal erythroid progenitors
exhibit maximal cycling activity and have shorter doubling
times than adult bone marrow erythroid progenitors resulting in
a rapid expansion of these progenitors during development. The
most immature lineage committed erythroid progenitor is the
Burst Forming Unit Erythroid (BFU-E), which form large burst
colonies after 7 days in culture. Analysis of bone marrow BFU-
E showed that they required erythropoietin (Epo) and a second
signal referred to as a Burst promoting activity or BPA to form
colonies in vitro. Unlike bone marrow progenitors, human fetal
liver progenitors can give rise to bursts in the presence of Epo
alone without any added BPA, which further underscores the
differences between adult bone marrow erythropoiesis and fetal
liver erythropoiesis (Emerson et al., 1989; Valtieri et al., 1989).
In addition to the progenitors, the fetal liver microenvironment
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embryo. In vitro experiments have shown that fetal liver stromal
cell lines have the unique ability to promote erythropoiesis
when compared to bone marrow stromal cell lines (Ohneda et
al., 1990; Slaper-Cortenbach et al., 1987).
The expansive erythropoiesis of the fetal liver is thought to be
mechanistically similar to stress erythropoiesis in adult mice. In
response to acute anemia, erythropoiesis is up-regulated in the
spleen and robustly produces new erythrocytes (Lenox et al.,
2005). Fetal liver erythropoiesis and adult stress erythropoiesis
are in stark contrast to adult bone marrow erythropoiesis, which
is primarily homeostatic. This relationship between fetal liver
and adult stress erythropoiesis is evident in mice with a mutation
at the flexed-tail (f) locus. f/f embryos exhibit a severe micro-
cytic, hypochromic fetal anemia (Bateman and Cole, 1972;
Gruneberg, 1942a,b). The livers of these embryos are smaller
and have only about half the normal number of CFU-E (Cole and
Regan, 1976). Despite this severe defect in the erythroid lineage,
the number of CFU-S in the fetal liver is not different from the
control embryos suggesting this defect is specific to the ery-
throid lineage (Bateman and Cole, 1972; Gruneberg, 1942a,b;
Thompson et al., 1966). The anemia is most severe early in fetal
development and gradually improves such that the anemia
resolves about 2 weeks after birth. This time corresponds to the
development of the bone marrow as the primary erythropoietic
organ. As adults, f/f mice have normal blood values but are
unable to respond rapidly to acute erythropoietic stress. When
challenged with an acute anemia, the control mice respond by
inducing the rapid expansion of erythroid progenitors in the
spleen but in the f/f mice, this response is delayed (Coleman et
al., 1969; Lenox et al., 2005). These data demonstrate that f/f
mice have a defect in expansive erythropoiesis both during fetal
life and during response to acute anemia in the adult.
We have previously shown that f/f mice have a mutation in
the Smad5 gene, which results in a defect in their ability to
respond to acute anemia (Hegde et al., 2007; Lenox et al.,
2005). Smad5 functions as a receptor activated Smad down-
stream of the receptors for BMP2, 4 and 7 (Huber et al., 1998;
Massague, 2000; Massague and Chen, 2000). Previous work
has implicated BMP's, in particular BMP4, in the development
of mesodermal cells that will give rise to hematopoietic cells
early in development (Huber et al., 1998). We have observed
that the BMP4 is rapidly induced during expansive erythropoi-
esis in the spleen and is involved in the mobilization of a distinct
population of stress erythroid progenitors, which we term stress
BFU-E, during the recovery from acute anemia (Lenox et al.,
2005). Similar to human fetal liver BFU-E, stress BFU-E
exhibit faster doubling times and are capable of forming BFU-E
colonies in the presence of Epo alone. These observations
suggest that fetal liver erythropoiesis may be mechanistically
similar to splenic stress erythropoiesis and utilize the BMP4/
Smad5 signaling pathway to expand progenitors.
In this report we show that the fetal liver contains two
populations of erythroid progenitors. One population behaves
like steady state bone marrow BFU-E in that they require both
Epo and a BPA to form colonies. The second population exhibits
the properties of stress BFU-E in that they are able to form BFU-E in the presence of Epo alone and respond to BMP4. f/f mutant
mice exhibit a delay in the expansion of these fetal stress BFU-E,
which leads to the fetal anemia in these mutant embryos. The
expansion of the stress BFU-E in the fetal liver is correlated with
the induction of BMP4 expression by stromal cells in the fetal
liver. The delay in stress BFU-E expansion in f/f embryos is not
caused by excessive apoptosis or defects in terminal erythroid
differentiation, but rather a delay in the expansion of progenitor
cells. In addition we demonstrate that stress BFU-E are present
in the CD31+Kit+Sca1−Lin− (CD31+) fraction of fetal liver
cells. This population is reduced by 50% in the f/f mice and is
defective in forming stress BFU-Ewhen compared to the CD31+
fetal liver cells from wild type controls. Furthermore, we show
that the yolk sac contains stress BFU-E and the expansion of
stress BFU-E is delayed in f/f yolk sacs, which may also
contribute to the increased severity of their anemia early in
development. Taken together these data support a model where
the BMP4 dependent stress erythropoiesis pathway plays a key
role in the expansion of erythroid progenitors at critical junctures
during development in the yolk sac and fetal liver.
Methods
Preparation of fetal liver
C57BL/6 and C57BL/6-f/f mice were bred in our colony. All mice were
approximately 2 months old, controls were age matched. Timed pregnancies
were set up in the late afternoon and the appearance of vaginal plug in the
morning was designated as 0.5 days (E0.5). Pregnant mice were sacrificed at
different time points between E12.5 and E18.5. Fetal livers were dissected from
embryos and single cell suspension was made by passing liver cell suspensions
through 18G and 21G needles and through a nylon cell strainer. Absolute
numbers of fetal liver cells were determined by standard cell counting. For
immunofluorescence, the isolated fetal livers were fixed in 4% Paraformalde-
hyde, embedded in paraffin and sectioned for analysis. All procedures were
approved by the IACUC at the Pennsylvania State University.
Immunofluorescence studies
Paraffin embedded fetal liver sections were deparaffinized and rehydrated
through an ethanol series as described previously (Lenox et al., 2005). Sections
were incubated for 1 h each at room temperature with the primary antibody and
then washed with PBS. Anti-BMP4 (Novocastra Laboratories/Vector Labora-
tories, Burlingame, CA) and Smad5 (Santa Cruz Biotechnology, Santa Cruz, CA)
antibodies were used at the manufacturer's recommended dilutions (Chagraoui et
al., 2003; Lenox et al., 2005). Alexa Fluor (Molecular Probes, Eugene, OR)
fluorescent secondary antibodies were then added. For negative controls,
appropriate isotype controls were used. Sections were mounted in Slowfade
(Molecular Probes, Eugene, OR) and analyzed by digital microscopy (Olympus
BX-60 Epi-Fluorescence Digital digital microscope).
Erythroid progenitor assays
5×105 fetal liver cells were plated in methylcellulose media containing 3 U/
ml Epo (M3334 Stem Cell Technologies, Vancouver, BC). 15 ng/ml BMP4
(R&D Systems, Minneapolis, MN) and 2.5 ng/ml IL-3 (Sigma, St. Louis, MO)
were added wherever indicated. Replicates were plated and at least three inde-
pendent experiments were performed for each time point. BFU-E was scored by
acid Benzidine staining after incubation for 5 days (Finkelstein et al., 2002).
TUNEL assay for apoptosis
E14.5 fetal liver sections were prepared and permeabilized as described
earlier. Apoptosis in tissue sections was detected using an in situ cell death
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recommendations.
Fluorescence activated cell sorting analysis
E14.5 fetal liver single cell suspensions were stained with biotin-conjugated
Mouse lineage Panel (BD Pharmingen, San Diego, CA). Biotinylated Sca-1 (BD
Pharmingen, San Diego, CA) was added to the cocktail and the cells were
negatively selected for using EasySep Biotin Selection Kit for Mouse Cells
(StemCell Technologies, Vancouver, BC, Canada). Cells were stained with
fluorescein isothiocyanate-conjugated anti-Kit antibody (BD Pharmingen, San
Diego, CA) and phycoerythin-conjugated anti-CD31 (Mec 13.3) (BD Pharmingen,
San Diego, CA) and sorted using a Coulter Elite ESP flow cytometer (Coulter
Electronics, Hialeah, FL) for Lin−Scal1−cKit+ CD31+/− cell populations
(Baumann et al., 2004). Fetal liver MEPs were sorted as previously described
(Lenox et al., 2005; Traver et al., 2001). 25,000 cells each were plated in triplicates
in methylcellulose and scored as described above.
Differentiation of fetal erythroid progenitors
E14.5 fetal liver cells were isolated and sorted for Lin−Kit+ cells as
described above. Sorted cells were either analyzed directly or plated in an
erythroid differentiation media (Isocove's Modified Dulbecco's Medium was
supplemented with 5% Fetal Bovine Serum, 3 U/ml Epo and 10 μg/ml Insulin)
for 2 days and then analyzed (Panzenbock et al., 1998). The cells were then
cytospun on to slides and then stained with o-Dianisidine (Sigma, St. Louis,
MO) and counterstained with Wright–Giemsa cytology stain.
Yolk sac cell isolation and co-culture with fetal liver stromal cells
Yolk sacs were dissected out of embryos at particular time points as described
earlier. Single cell suspensions of tissues were obtained by treating with 0.25%
Trypsin/EDTA (Cellgro) for 3–4 min at 37 °C with vigorous pipetting as
described earlier (Palis et al., 2001). Cell count and viability was quantitated after
staining with Trypan Blue. 0.67 embryo equivalents were plated in each well in
triplicates either directly or onto AFT024 cells. Co-culture with AFT024 cells
was done as follows. AFT024 cells were grown into confluency at 33C and then
weremoved to 37C to stop their proliferation. A single cell suspension of yolk sac
cells was layered onto the AFT024 monolayers. The cells were co-cultured for
48 h. The cells were trypsinized and plated in methylcelluose media containing
Epo or Epo+IL-3 as described above. BFU-E were scored following acid
benzidine staining after 5 days of methylcellulose culture.
Western blot analysis
Whole fetal livers were dissected from mutant and control mice on the
indicated days. The livers were lysed in RIPA buffer and whole cell lysates were
generated. Equal amounts of protein were loaded on SDS-PAGE gels and
blotted to nitrocellulose membrane. The membranes were blocked and then
incubated with anti-Smad5, anti-Phospho Smad1, 5, 8 (Cell Signaling, Danver,
MA) or anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies. In
separate experiments, western blots of fetal liver lysates were probed with anti-
BMP4 antibodies (Novocastra Laboratories/Vector Laboratories, Burlingame,
CA) and then probed with anti-actin antibodies as a loading control. The
membranes were washed and incubated with secondary antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) conjugated to horseradish peroxidase. Protein
antibody complexes were visualized using ECL plus western blotting detection
system (GE Healthcare, Buckinghamshire, UK).
Results
Fetal liver contains two BFU-E populations, which exhibit
properties of either stress BFU-E or steady State BFU-E
In our previous work we showed that during the recovery
from acute anemia, a specialized population of stress erythroidprogenitors, which we termed stress BFU-E, are rapidly
expanded in the adult spleen. The properties of these BFU-E
are distinct from bone marrow steady state BFU-E. Stress BFU-
E are resident in the spleen and rapidly form large BFU-E
colonies when cultured in the presence of Epo alone (Lenox et
al., 2005). Similar to the spleen, some fetal liver erythroid
progenitors have characteristics distinct from their adult bone
marrow counterparts. While bone marrow BFU-E require the
presence of a BPA along with Epo to form BFU-E, studies in
human fetal liver have shown that some fetal BFU-E can
respond to Epo alone without addition of any BPA(Emerson et
al., 1989; Valtieri et al., 1989). In many ways, these fetal liver
erythroid progenitors are more similar to the stress BFU-E,
which require BMP4, SCF and hypoxia for their expansion
(Lenox et al., 2005; Perry et al., 2007). f/f mice exhibit a
delayed expansion of stress BFU-E because of impaired BMP4
dependent signaling. Because f/f mutant embryos also have a
defect in the fetal liver erythropoiesis, we looked for the
presence of stress BFU-E in the fetal liver and asked whether
these cells were defective in the f/f mice. We observed that there
is a significant expansion in the relative number of stress BFU-E
at E15.5 in control mice, which correlates with the maximal
erythropoietic activity in the organ and this expansion is
sustained until E16.5 (Fig. 1A). At E18.5, when most of the
erythropoietic activity in the fetal liver is finished, the number
of stress BFU-E had decreased to the low levels observed at
E12.5. In contrast, the expansion in the relative numbers of
stress BFU-E in f/f embryos is not observed until E16.5. At this
time f/f and control embryos exhibit similar numbers of stress
BFU-E, which are not significantly different from high levels of
stress BFU-E observed in control embryos at E15.5. Similar to
control embryos, the relative numbers of stress BFU-E in f/f
embryos decreases between E16.5 and E18.5 such that by E18.5
the number of stress BFU-E is similar to the low levels observed
at E12.5. These data demonstrate that f/f embryos exhibit not
only a delay in the increase in the relative numbers of stress
BFU-E but also a diminished response when compared to
control embryos.
It has been shown that f/f mice have smaller fetal livers and
contain decreased number of mature erythroid progenitors and
identifiable erythroblasts (Cole and Regan, 1976).We determined
the number of cells in the fetal liver at various time points and
plotted the number of stress BFU-E colonies per fetal liver (Fig.
1B). The difference between stress BFU-E in f/f and control fetal
livers is even more striking when the smaller fetal livers of the f/f
embryos is taken into account. At E15.5, there is approximately a
7 fold decrease in the number of stress BFU-E in f/f fetal livers.
The maximal increase in stress BFU-E in f/f embryos was
observed at E16.5. Similar to what we observed when relative
numbers of stress BFU-E were examined, the total number of
stress BFU-E at E16.5 f/f embryos was not significantly different
than control E16.5 embryos and this number, although less, was
not significantly fewer than the total number of stress BFU-E
observed in E15.5 control embryos. These data mirror the data for
the relative numbers of stress BFU-E and show that, even though
the f/f fetal liver was capable of expanding stress BFU-E at E16.5
similar to controls, the impaired expansion at E15.5 makes their
Fig. 1. Expansion of Stress BFU-E in the fetal liver of f/f and control mice. Fetal
liver cells were isolated on the indicated days during fetal development and
plated in methylcellulose media containing only Epo. BFU-E were scored after
5 days in culture. (A) Relative number of BFU-E per 5×105 fetal liver cells. (B)
Total number of stress BFU-E per fetal liver. The significance of the differences
between f/f and control discussed in the text are indicated on the figure. If no
other p value is given then the difference was not significant.
Fig. 2. Expansion of steady state BFU-E in the fetal liver of f/f and control mice.
Fetal liver cells were isolated on the indicated days during fetal development and
plated in methylcellulose media containing Epo+IL-3. BFU-E were scored after
5 days in culture. The number of Epo+BPA BFU-E was calculated by
subtracting the number of Epo-only BFU-E from the number of Epo+IL-3
BFU-E. (A) Relative BFU-E per 5×105 fetal liver cells. (B) Total number of
steady state BFU-E per fetal liver. The significance of the differences between f/f
and control discussed in the text are indicated on the figure. If no other p value is
given then the difference was not significant.
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embryos is most severe early in fetal development (Gruneberg,
1942a,b; Kamenoff, 1935). Our data suggests that the delayed
and diminished expansion of stress BFU-E in f/f embryos results
in the fetal anemia.
Unlike the spleen, which contains primarily stress BFU-E,
the fetal liver also contains BFU-E, which are similar to bone
marrow steady state BFU-E and require both a BPA and Epo to
form a BFU-E colony. We assayed for steady state BFU-E at
various times during embryogenesis by culturing fetal liver cells
in media containing Epo alone or Epo and IL-3, scoring total
BFU-E colonies (Epo+IL-3) and then subtracting out the
number of Epo-only BFU-E. We observed that at no time point
is there a significant difference in the relative numbers of
steady-state BFU-E in the control mice compared to the f/f mice
(Fig. 2A). Although the relative numbers of steady state BFU-E
are similar between f/f and control mice, we took into account
the smaller fetal livers present in the f/f embryos and calculated
the total number of “steady state” BFU-E per fetal liver. In
control embryos the peak expansion of steady state BFU-E is
observed at E15.5 and E16.5. After this time the number of
steady state BFU-E decreases such that at E18.5 low levels are
observed. In contrast, f/f embryos exhibit a small, but significantdeficit at E14.5 and E15.5 (Fig. 2B). By E16.5, however, the
total number of steady state BFU-E in f/f embryos is not
significantly different than control E16.5 embryos or E15.5
embryos. These data show that the delayed and diminished
expansion of steady state BFU-E in the mutant embryos is
similar to what we observed for stress BFU-E. However, the
defect in steady state BFU-E is much less severe in that the
difference at E14.5 or E15.5 is approximately 2 fold, which
parallels the difference in fetal liver cellularity.
Taken together the analysis of BFU-E demonstrates that two
populations of BFU-E exist in the fetal liver. One population
responds to Epo alone and exhibits properties of stress BFU-E
(Lenox et al., 2005). These progenitors are strongly affected in
f/f mutant embryos. While the second population, which
exhibits properties of steady state BFU-E in that they require
a BPA, is less affected in f/f mice. This observation is similar to
adult f/f mice, which do not exhibit a defect in the number of
bone marrow steady state BFU-E, but exhibit a delayed
expansion of stress BFU-E in the spleen during the recovery
from acute anemia (Gregory et al., 1975; Lenox et al., 2005).
The decrease in stress BFU-E could potentially make a larger
contribution to the severity of the anemia beyond the simple
decrease in BFU-E numbers. Our earlier observations that stress
BFU-E generate significantly larger bursts than steady state
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significant impact on fetal red cell production (Lenox et al.,
2005; Perry et al., 2007).
BMP4 expression correlates with the level of erythropoietic
activity in the fetal liver
We investigated the expression of BMP4 between E12.5 and
E18.5 when erythropoiesis in the fetal liver is active. We
observed very little expression of BMP4 at E12.5, when the
fetal liver is still being seeded by hematopoietic cells from yolk
sac and AGM regions. BMP4 expression starts at approximately
E13.5 and reaches maximal levels by E14.5, which coincides
with the maximal erythropoietic activity in the organ (Cole and
Regan, 1976) (Fig. 3A). Thereafter, the BMP4 protein level
decreases, reaching basal levels by E18.5. In contrast, f/f em-
bryos exhibit very little expression of BMP4 protein up to
E14.5. However at E15.5, BMP4 expression is observed and
reaches maximal levels by E16.5; which coincides with the
maximal erythropoietic activity in f/f mice (Cole and Regan,
1976) (Fig. 3A). This delay is similar to the delay in the ex-
pression of BMP4 seen in the spleens of adult f/fmice followingFig. 3. Expression of BMP4 in the fetal liver of f/f and control mice. (A) (top) Fetal liv
stained with anti-BMP4 antibodies. (Bottom) Negative control staining with isotype
embryos. (B)Western blots of whole fetal liver lysates from the indicated days of deve
control.induction of acute anemia (Lenox et al., 2005). We further
compared the expression of f/f fetal liver BMP4 expression with
control fetal liver expression by western blot analysis. We
examined expression at E14.5, 15.5 and 16.5; timepoints when
the differences in stress BFU-E expansion were observed. Fig.
3B shows that at E14.5 control fetal livers show significantly
more BMP4 expression by western blot. Over the next 2 days of
development, the expression of BMP4 decreases in control
embryos while it increases in f/f fetal livers. These data support
the idea that f/f embryos exhibit a defect in BMP4 expression in
the fetal liver.
BMP4 expression does not co-localize with CD45+ or Kit+
cells, which shows that hematopoietic progenitor cells in the fetal
liver are not the source of BMP4. This situation is similar to what
we have observed in the adult spleen during the recovery from
acute anemia (P. Porayette and RF Paulson unpublished observ-
ations). However, when we stain fetal liver sections with anti-
bodies to hepatocyte specific markers, we observed that a subset
of BMP4 expressing cells were hepatocytes. In addition, staining
for stromal cell markers, cytokeratin 8 (CK8) and α-smooth
muscle actin (ASMA) demonstrated that BMP4 is also expressed
by stromal cells in the fetal liver (Supplementary Fig. 1).ers from control and f/f embryos isolated at the indicated days were sectioned and
control antibodies of fetal liver sections from C57BL/6-f/f and C57BL/6 control
lopment probed with anti-BMP4 antibodies and anti-actin antibodies as a loading
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Our analysis of stress BFU-E in adults showed that culturing
spleen cells from non-anemic mice with BMP4 resulted in an
increase in stress BFU-E (Lenox et al., 2005; Perry et al., 2007).
We tested whether culturing fetal liver cells from control and f/f
embryos in media containing BMP4 and Epo resulted in
increased BFU-E when compared with cultures containing Epo
only. At E12.5 and E13.5 we observed a small but significant
increase in BFU-E when cells were plated in media containing
BMP4. However the effect of BMP4 was gradually lost such
that by E15.5 no effect of BMP4 was observed (Fig. 4A). In
contrast, in f/f fetal liver cells, BMP4 is unable to increase the
number of BFU-E at any of the time points due to the defect in
Smad5 gene. The lack of a response to BMP4 in the control
mice at E15.5 and later time points might be because these
cells have already been exposed to BMP4, which is induced in
vivo at E14.5 (Fig. 3A) and thus are refractory to the effects of
any BMP4 added in vitro. We have made a similar observation
in the spleen during the recovery from acute anemia. Once
BMP4 expression starts 24 h after anemia induction, the res-Fig. 4. Effect of BMP4 on Epo only and Epo+IL-3 BFU-E formation. (A) (left) Fetal l
in methylcellulose media containing Epo alone or Epo+BMP4. The fold increase in t
Significant increases in the number of Epo-only BFU-E following BMP4 treatment a
control fetal liver cells probed with anti-Phospho-Smad1, 5, 8, anti-Smad5 and β-actin
indicated media±BMP4 to test the effect of BMP4 on the formation of Epo-only or E
value is given then the difference was not significant.ponse of spleen cells to BMP4 is lost (J. Perry and RF Paulson
unpublished).
We examined the expression of Smad5 and the extent of
BMP4 induced phosphorylation of Smad5 in E14.5 fetal liver
cells (Fig. 4A). We observed that in control fetal liver cells,
Smad5 is highly expressed and phosphorylated whereas in f/f
embryos little Smad5 is expressed. However, despite the low
levels of Smad5, it appears to be phosphorylated. Therefore the
defect in BMP4 dependent expansion of stress BFU-E appears
to be caused by low levels of full length Smad5.
Our previous work showed that BMP4 had no effect on bone
marrow steady state BFU-E (Lenox et al., 2005). However, our
observation that the total number of steady state BFU-E in the
f/f fetal liver is decreased approximately 2 fold suggests that
BMP4 signaling may play a role the expansion of steady state
BFU-E. We tested this possibility by treating E12.5 fetal liver
cells from f/f and control embryos with BMP4 and determined
whether the number of steady state BFU-E increased. Fig. 4B
shows that stress BFU-E are significantly increased when
BMP4 is added to the culture, but this treatment had no effect on
the number of steady state BFU-E. As shown in Fig. 4A, f/f fetaliver cells were isolated on the indicated days during fetal development and plated
he number of BFU-E (Epo+BMP4/Epo-only) was calculated at each time point.
re indicated on the figure. (right) Western blot of cell lysates from E14.5 f/f and
as a loading control. (B) Fetal liver cells were isolated on E12.5 and plated in the
po+IL-3 BFU-E. Significant differences are indicated on the figure. If no other p
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number of stress BFU-E. Furthermore, steady state BFU-E from
f/f exhibited responses indistinguishable from control embryos
following treatment with BMP4. These observations are con-
sistent with our model that BMP4 does not affect the number of
steady state BFU-E and that the f/f mutation primarily affects
the stress BFU-E in the fetal liver.
The f/f mutation does not cause increased apoptosis or cause
defects in erythroid differentiation
Recent work has suggested that the regulation of Fas
mediated apoptosis of erythroid progenitors plays a role in the
expansion of erythroblasts in response to erythropoietic stress
(Liu et al., 2006). The defect in the expansion of stress BFU-E in
f/f mutant embryos could result from an increase in apoptosis.
We investigated this possibility by performing TUNEL staining
on sections of E14.5 fetal livers from f/f and control embryos.
Fig. 5A shows that there is no difference in the number of
TUNEL+ cells in f/f fetal livers when compared with control,Fig. 5. f/f embryos do not exhibit excessive apoptosis or defects in erythroid
terminal differentiation. (A) Fetal liver sections from E14.5 C57BL/6-f/f and
C57BL/6 control embryos were stained for apoptotic cells by TUNEL assay.
Bright field views are shown to the left. (B) Fetal liver cells from E14.5
C57BL/6-f/f and C57BL/6 control embryos were incubated in erythroid
differentiation media for 48 h. The cells prior to culture (top) and after culture
(bottom) were stained with Wright–Giemsa and o-Dianisidine stain to
identify hemoglobinized cells.suggests that apoptosis is not the cause of the delayed expansion
of stress BFU-E.
The scoring of the BFU-E colony assay relies on our ability
to stain terminally differentiated erythroid cells with benzidine.
Therefore a defect in terminal erythroid differentiation would
affect our ability to identify BFU-E. We tested whether fetal
liver cells from f/f mice could terminally differentiate when
plated in media containing Epo and insulin which promotes the
terminal differentiation of erythroid cells in vitro (Panzenbock
et al., 1998). We observed no difference in the ability of f/f fetal
liver cells to differentiate when compared with control cells
(Fig. 5B). Taken together these data support a model where the
anemia of f/f embryos is caused by defect in the expansion of
progenitor cells.
The majority of stress BFU-E are present in the
CD31+Kit+Sca1−Lin− population
Our analysis of erythroid progenitors in the spleen has shown
that stress BFU-E capable of forming Epo-only BFU-E share the
same surface phenotype as the Megakaryocyte–Erythroid Pro-
genitor (MEP) (Akashi et al., 2000; Lenox et al., 2005). Analysis
of fetal liver progenitors has shown thatMEPs and their precursors,
CommonMyeloid Progenitors (CMP) are present in the fetal liver
(Traver et al., 2001). We sorted MEPs from E14.5 fetal liver and
analyzed their ability to form stress BFU-E. Our analysis of MEPs
showed that they have only minimal ability to form stress BFU-E
colonies under our culture conditions (Fig. 6A). Recently, another
population of erythroid progenitors was identified that are distinct
from theMEPs and are characterized by the expression ofCD31 or
PECAM (Baumann et al., 2004). This population (CD31+)
exhibits a Kit+CD31+ Sca1−Lin− surface phenotype. Analysis of
the CD31+ population in adult bone marrow showed that these
cells could provide effective short-term radioprotection by
transiently contributing to the erythroid lineage. We sorted these
cells from the fetal liver and showed that this population was
capable of forming stress and steady state BFU-E (Fig. 6A). In
contrast, the CD31− population was able to form very few steady
state BFU-E and no stress BFU-E, suggesting that the majority of
the stress BFU-E forming activity was within the CD31+
population. We extended our analysis of the CD31+ population
by analyzing these cells in the fetal liver of E14.5 f/f embryos,
which showed that their numbers are reduced 2 fold in these
embryos compared to the control (Fig. 6B). Functional analysis of
BFU-E colony forming ability of the CD31+ population from f/f
mice showed that these cells form only half the number of stress
BFU-E compared to the control mice despite the observation that
the total number of BFU-E (stress+steady state) were not different
(Fig. 6C). These data show that the CD31+ erythroid progenitor
population contains the majority of the stress BFU-E and CD31+
cells from f/f fetal liver exhibit defects in stress BFU-E formation.
Stress BFU-E are present in the yolk sac and are reduced in f/f
embryos
Recent work in zebrafish has shown that Smad5 and Smad1
are required for definitive hematopoiesis (McReynolds et al.,
Fig. 6. CD31+Kit+Sca1−Lin− population contains both Epo-only and Epo+IL-3 BFU-E. (A) Fetal liver cells were isolated from E14.5 control embryos and sorted for
CD31+Kit+Sca1−Lin−, CD31−Kit+Sca1−Lin− or MEP cells. 25,000 cells were plated in methylcellulose media containing Epo or Epo+IL3. BFU-E were scored
after 5 days in culture. (B) Representative flow diagrams from E14.5 control and f/f fetal liver cells gated on Sca1−Lin− cells. (right) Graph showing the average
percentage of fetal liver cells that are CD31+Kit+Sca1−Lin− in from E14.5 control and f/f mice. (C) Stress BFU-E and total BFU-E present in the CD31+Kit+Sca1−
Lin− population of cells from the fetal livers of control or f/f mice were determined. Significant differences are indicated on the figure. If no p value is given then the
difference was not significant.
31P. Porayette, R.F. Paulson / Developmental Biology 317 (2008) 24–352007). Murine Smad5−/− embryos die prior to the onset of
definitive erythropoiesis and no studies using conditional alleles
of Smad5 have examined the role of Smad5 in the development
of definitive erythroid progenitors (Yang et al., 1999). Erythroid
progenitors do not develop de novo in the fetal liver and it has
been proposed that stem cells and progenitors from the yolk sac
and AGM region of the embryo seed the fetal liver (McGrath
and Palis, 2005; Palis et al., 1999). Definitive erythroid pro-
genitors, BFU-E, are first observed in the yolk sac at E8.25.
These BFU-E rapidly expand during the next 2 days of dev-elopment and are thought to seed the fetal liver with an initial
wave of definitive erythroid progenitors. In order to determine
whether stress BFU-E are present in the yolk sac, we directly
plated yolk sac cells from E10.5, E11.5 and E12.5 embryos in
methylcellulose media containing Epo alone or Epo+IL-3 (Fig.
7A). In control E10.5 embryos, yolk sac cells generated signi-
ficantly more total BFU-E than mutant E10.5 yolk sac cells;
while at E11.5 and E12.5 the total number of BFU-E generated
in control versus mutant yolk sacs was not significantly diffe-
rent (Fig. 7B). When we analyzed stress BFU-E, we observed
Fig. 7. Yolk sac contains stress BFU-E and progenitor cells that develop into stress BFU-E when Yolk sac cells are plated on fetal liver stromal cells. (A) Schematic of
the direct plating of yolk sac cells and co-culture with AFT024 cells prior to plating. (B) Total number of BFU-E (stress BFU-E+ Steady State BFU-E) present in the
yolk sac of C57BL/6-f/f and C57BL/6 control mice on the indicated days of embryonic development. *pb0.05 when E10.5 control yolk sacs were compared with
E10.5 mutant and E11.5 mutant or control yolk sacs. (C) Left panel: Yolk sac cells from E10.5, E11.5 and E12.5 control and f/f embryos were directly plated in media
containing Epo alone or Epo+IL-3. BFU-E were scored 5 days later. Right panel: Yolk sac cells from E10.5 and E11.5 control and f/f embryos were co-cultured on
AFT024 fetal liver stromal cells for 48 h and then plated in methylcellulose media containing Epo alone or Epo+IL-3. BFU-E were scored 5 days later. Epo+IL-3
BFU-E were calculated by subtracting the number of Epo-only BFU-E from the total number of BFU-E formed in Epo+IL-3. The significance of the differences
between different time points in f/f and control yolk sacs as discussed in the text are indicated on the figure. If no other p value is given then the difference was not
significant. (D) The fold increase in stress BFU-E observed when E10.5 and E11.5 yolk sac cells were co-cultured AFT024 cells.
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similar relative numbers of stress BFU-E. However, at E11.5,
the number of stress BFU-E had significantly increased in the
control yolk sac when compared to control E10.5 yolk sacs
(pb0.05). In contrast, the relative number of stress BFU-E in
E11.5 f/f yolk sacs was unchanged from the number observed at
E10.5 and significantly less than the number observed in control
E11.5 yolk sacs (pb0.05) (Fig. 7C). At E12.5, both mutant and
control yolk sacs exhibited similar, low relative numbers of
stress BFU-E. This analysis also demonstrates that the
percentage of total BFU-E that are stress BFU-E dramatically
increases in control yolk sacs from E10.5 to E11.5 (6.2% stress
BFU-E at E10.5 to 45% stress BFU-E at E11.5). This increase is
not observed in f/f yolk sacs where the percentage of total BFU-
E that are stress BFU-E remains constant (13.2% stress BFU-E
at E10.5 and 11% stress BFU-E at E11.5). This increase in the
percentage of stress BFU-E occurs despite the fact that there is
no significant difference in the relative numbers of total BFU-E
between control and mutant yolk sacs. These data show that the
expansion of stress BFU-E in the f/f mutant yolk sacs is
defective.
The observation that f/f yolk sacs exhibit a defect in the
expansion of stress BFU-E at E11.5 is not consistent with our
observation that at E12.5 f/f and control fetal livers contain
similar numbers of stress BFU-E. One possibility is that stress
BFU-E could develop in the AGM region and then seed the fetal
liver. We tested whether AGM region cells could generate stress
BFU-E when plated in methylcelluose media, however no BFU-
E were observed in these cultures even when IL-3 was included
in the media (Data not shown). These results are consistent with
earlier reports that the AGM region is not a site of erythropoiesis
in the mouse embryo (Godin et al., 1999). A second possibility
is that progenitors from the yolk sac differentiate into stress
BFU-E when they seed the fetal liver. These progenitors are not
stress BFU-E, but would differentiate into stress BFU-E in
response to a signal or signals in the fetal liver microenviron-
ment. Recently we have demonstrated that bone marrow cells
can differentiate into stress BFU-E when they come in contact
with the spleen microenvironment (J. Perry and RF Paulson
unpublished observations). Using these data as a guide we
tested whether co-culturing yolk sac cells on fetal liver stromal
cells could induce the development of stress BFU-E (Fig. 7A).
We used AFT024 fetal liver stromal cells, which were derived
from E14.5 fetal liver (Moore et al., 1997). These cells have
been shown previously to support the expansion of stem and
progenitor cells in culture (Chagraoui et al., 2003; Moore et al.,
1997). Plating control E10.5 yolk sac cells on AFT024 cells led
to a 10 fold increase (p=0.006) in the number of stress BFU-E
when compared to direct plating (Fig. 7D). In contrast f/f yolk
sac cells exhibited a small (∼2 fold) increase in stress BFU-E
when compared to direct plating that was not statistically
significant (p=0.078). However the opposite was observed
when E11.5 yolk sac cells were co-cultured with AFT024 cells.
Co-culturing control yolk sac cells resulted in a small increase
(∼2 fold, p=0.08), while f/f yolk sac cells showed a 6 fold
increase in stress BFU-E (pb0.001) when compared to direct
plating. Co-culturing either mutant or control E12.5 yolk saccells with AFT024 cells did not result in an increase in stress
BFU-E. In addition to the increase in stress BFU-E, co-culturing
on AFT024 cells lead to an increase in the percentage of total
BFU-E that are stress BFU-E such that stress BFU-E become
the predominate form of BFU-E in the cultures (Fig. 7C). This
increase in the percentage of stress BFU-E was not observed
when E10.5 mutant yolk sac cells were co-cultured with
AFT024 cells. These data show that E10.5 control yolk sacs
contain more progenitors with the potential to become stress
BFU-E when co-cultured with fetal liver stromal cells than
E10.5 f/f yolk sacs. However, the situation is reversed at E11.5
where f/f yolk sacs exhibit a greater potential to generate stress
BFU-E following co-culture with fetal liver stromal cells (Fig.
7D). These observations suggest a model where definitive
hematopoietic progenitors in the yolk sac interact with fetal
liver stromal cells and develop into stress BFU-E. Our data
suggests that despite the deficit in stress BFU-E in E11.5 yolk
sacs of f/f embryos, they contain progenitors that can develop
into stress BFU-E when they interact with a signal or signals in
the fetal liver microenvironment. It appears that the maximum
development of these progenitors is delayed in f/f yolk sacs
from E10.5 to E11.5, but despite this delay, the f/f E12.5 fetal
livers contain similar numbers of stress BFU-E as control fetal
livers.
Discussion
The need for oxygen necessitates that the hematopoietic and
cardiovascular systems develop early during embryogenesis. To
meet the demands of the fetus, fetal liver hematopoiesis is
predominately erythropoietic. Using our previous work on the
erythroid response to acute anemia as a paradigm, these data
suggest that the oxygen needs of the rapidly expanding embryo
activates the BMP4 dependent stress erythropoiesis pathway in
the fetal liver, which drives the expansion of stress erythroid
progenitors. Our observations suggest that mid gestation
(E13.5–E15.5) is a critical juncture in development where an
up-regulation of erythropoiesis is required and steady state
erythroid progenitors are unable to produce sufficient erythro-
cytes. The BMP4 dependent expansion of stress BFU-E fills
this need because stress BFU-E differentiate faster and have a
larger capacity to generate mature erythrocytes than steady state
BFU-E (Lenox et al., 2005; Perry et al., 2007). Taken together
these data suggest a new model for fetal erythropoiesis where
the activation of the BMP4 dependent stress erythropoiesis
pathway is required to rapidly generate erythrocytes for the
developing embryo.
BMP4 regulates the expansion of stress BFU-E in the spleen,
which exhibit properties distinct from bone marrow steady state
BFU-E (Lenox et al., 2005). Analysis of erythroid progenitors in
control embryos showed that the progenitors that expand at E14.5
exhibit properties of stress BFU-E. Like stress BFU-E, these fetal
liver BFU-E are able to form colonies in media containing Epo
alone in 5 days of culture. This population of BFU-E initially
make up approximately 30% of BFU-E at E14.5, but by E15.5
when the maximum number of BFU-E are present in the fetal
liver, stress BFU-Emake up the majority of the fetal liver BFU-E.
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BFU-E returns to approximately 30%. Previous work has shown
that human fetal liver also contains a population of BFU-E that
respond to Epo alone. Interestingly this population is present
primarily during early gestation (9–10 weeks), while during later
fetal development (N17 weeks) BFU-E require both Epo and a
BPA (Emerson et al., 1989; Valtieri et al., 1989). The role of
BMP4 signaling in the expansion of these human fetal liver
BFU-E however, is not known.
Our previous analysis of adult stress erythropoiesis showed
that essentially all of the BFU-E in the spleen were stress BFU-E,
in contrast, the bone marrow contained primarily steady state
BFU-E. Here we show that the fetal liver contains both steady
state and stress BFU-E. Our data show that f/f exhibit a
significant decrease in both the relative number and total number
of stress BFU-E in the fetal liver at E15.5. These observations
are consistent with a model where the fetal anemia of f/f mutant
mice primarily results from their impaired ability to expand
stress BFU-E in response to BMP4 signaling. The delayed
expansion of stress BFU-E observed in f/f fetal livers also
explains the severe anemia exhibited early in fetal development,
which progressively improves during development.
In addition to the decrease in stress BFU-E, we observed a
small, approximately two fold, decrease in the number of
steady state BFU-E in f/f fetal livers. This decrease suggests
the possibility that BMP4/Smad5 dependent signaling could
also regulate the expansion of steady state BFU-E. However,
the addition of BMP4 to methylcellulose cultures of fetal liver
cells does not affect the number of steady state BFU-E in
control or f/f fetal liver cells suggesting that f/f steady state
BFU-E do not exhibit a cell intrinsic defect in responding to
BMP4. We feel that the most likely explanation for this
observation is that the two fold decrease in steady state BFU-E
is a consequence of the smaller fetal livers present in f/f
embryos. Previous work demonstrated that f/f fetal livers were
approximately two fold smaller than control fetal livers
(Bateman and Cole, 1972; Cole and Regan, 1976). The fetal
liver may contain only a certain number of niches for steady
state BFU-E, which would be decreased in number in the
smaller f/f fetal livers. This situation would lead to fewer
steady state BFU-E. This model would also predict that the
decrease in steady state BFU-E would parallel the difference
in fetal liver size and the relative numbers of steady state
BFU-E should not be significantly different between f/f and
control, which is what we observe.
The initial erythropoiesis in the yolk sac is primitive
erythropoiesis. Early work on f/f mutant embryos showed that
primitive erythropoiesis was unaffected in these mice (Russell,
1979). Similarly, Smad5−/− mice do not exhibit a defect in
primitive yolk sac erythropoiesis (Yang et al., 1999). Recent
work from zebrafish has shown that Smad1 and Smad5 are
required for definitive erythropoiesis (Gupta et al., 2006;
McReynolds et al., 2007). Definitive erythropoiesis in the
embryo is first observed in the yolk sac. Our data shows that
stress BFU-E develop in the yolk sac at E10.5 and E11.5 and
that f/f embryos exhibit a defect in this process, which may
contribute to the early anemia in these embryos.The prevailing model in the field is that definitive proge-
nitors in the yolk sac will seed the fetal liver. Paradoxically, we
observe that despite the defect in stress BFU-E in the f/f yolk
sac, E12.5 f/f mutant fetal livers have numbers of stress BFU-E
that are not significantly different from controls. Recent work
from our lab may explain this discrepancy. In the adult spleen,
all stress BFU-E differentiate during the recovery from acute
anemia, so they must be replaced. We observe that bone marrow
progenitors can replenish the BMP4 responsive stress BFU-E if
they migrate to the spleen. These data suggest that signals in the
spleen microenvironment cause the differentiation of bone
marrow progenitors into stress BFU-E (J. Perry and RF Paulson
unpublished data). Our data shows that co-culturing yolk sac
cells on fetal liver stromal cells can also promote the develop-
ment of stress BFU-E. This observation suggests that the yolk
sac produces progenitor cells that respond to signals in the fetal
liver microenvironment, which promote their differentiation
into stress BFU-E. In control embryos we observe a larger inc-
rease in stress BFU-E when E10.5 yolk sac cells are co-cultured
than when E11.5 cells are used. The opposite was true when f/f
yolk sac cells were used. In this case, co-culturing f/f E11.5 yolk
sac cells with AFT024 resulted in significantly more stress
BFU-E and a preferential increase in stress BFU-E. From these
observations we conclude that f/f mutant yolk sacs exhibit a
delay in the generation of progenitor cells in the yolk sac that
can respond to the fetal liver stromal signals, however, they are
able to overcome this delay such that by E12.5 the number of
stress BFU-E and CD31+Kit+Sca1−Lin− cells (Data not
shown) in the fetal liver are approximately equal to control
mice. Earlier work supports this model where the yolk sac
progenitors respond to signals in the fetal liver and differentiate
into definitive erythroid progenitors. These experiments showed
that co-culture of yolk sac with the fetal liver rudiment induced
the expansion of definitive erythropoietic progenitors (Cuden-
nec et al., 1981). This expansion was promoted by a signal
secreted by the liver. The identity of the signal in the fetal liver
is unclear. Our experiments used AFT024 cells, which were
made from E14.5 fetal liver (Moore et al., 1997) and express
BMP4 (P. Porayette and RF Paulson unpublished observations).
However, treatment of yolk sac cells with BMP4 did not affect
the number of stress BFU-E or the ratio of stress BFU-E to
steady state BFU-E (P. Porayette and RF Paulson unpublished
observations). Future work will be needed to identify the signals
involved in this process.
The most penetrant phenotype of f/f embryos is the se-
vere fetal anemia, which is in contrast to the lethality of the
Smad5−/− embryos. Our previous work showed that f mutant
mice have a defect in splicing of the Smad5 gene, where
the majority of the Smad5 mRNA is one of two mis-spliced
mRNAs. One of these aberrant splice forms when overexpressed
in an osteoblast cell line can inhibit BMP4 dependent differ-
entiation. Furthermore, f/Smad5− mice exhibit a less severe
phenotype than f/fmice, which suggests that f/f represents a gain
of function allele. So these data lead to the question of why f/f
mutant embryos survive, but Smad5−/− embryos die. Recently,
we have demonstrated that the splicing defect in f/f mice is
caused by a mutation in an intronic splicing regulatory element.
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tissue specific in its severity, in that some tissues exhibit low
levels of mis-spliced Smad5 mRNA. Furthermore the splice
forms vary between tissues (Hegde et al., 2007). These data
suggest that f represents an allele of Smad5 that specifically
affects stress erythropoiesis and in some strains, where tail
flexures and white belly spots are penetrant, chondrogenesis
and the development of melanocytes are also affected. How-
ever, other tissues that express Smad5 are unaffected.
In summary, we have demonstrated that the BMP4 de-
pendent stress erythropoiesis pathway plays a key role in the
expansion of erythroid progenitors in the fetal liver that
exhibit the properties of stress BFU-E found in the adult
spleen. These data suggest a model where the acute oxygen
needs of the growing fetus induce stress erythropoiesis to
rapidly generate large numbers of erythrocytes at a critical
time in fetal development.
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